# Efficacy of Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS)

> **NCT06201182** · NA · UNKNOWN · sponsor: **Thammasat University** · enrollment: 45 (estimated)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** FMT via rectal enema
- **DRUG:** FMT capsules
- **DRUG:** Placebo via rectal enema
- **DRUG:** Placebo capsules

## Key facts

- **NCT ID:** NCT06201182
- **Lead sponsor:** Thammasat University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-19
- **Primary completion:** 2024-08-19
- **Final completion:** 2024-08-19
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2024-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06201182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06201182, "Efficacy of Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT06201182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*